Feeds:
Posts
Comments

Posts Tagged ‘Abilify and autism’

The AP (http://tinyurl.com/abilify-for-autism 11/21) reported that the FDA “has approved top-selling Abilify [aripiprazole] as a treatment for autism-related irritability in children from the ages of six 17…Bristol-Myers Squibb Co. said Friday.” The agency’s “latest approval allows the” medication “to be used to treat symptoms associated with autism, such as aggression toward others, deliberate infliction of self-injury, tempter tantrums, and moodiness.” Bristol-Myers and Otsuka Pharmaceutical Co., collaborators on the development and distribution of Abilify in the US and Europe, “said in a statement that it was intended to be used as part of a more comprehensive treatment program that includes educational, psychological, and social aspects.”

Read Full Post »